Adiponectin, TNF-α and Inflammatory Cytokines and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
Abstract
Aims There has been growing evidence that adiponectin, tumor necrosis factor-α (TNF-α) and inflammatory cytokines involved in insulin resistance and may be attractive candidates for assessing risk of the incident type 2 diabetes (T2DM). A systematic review and meta-analysis of prospective studies was conducted to assess the associations of levels of serum adiponectin, TNF-α and inflammatory markers (Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Interleukin-18 (IL-18), C-reactive protein (CRP)) with risk of T2DM.Materials/methods We searched PubMed, ISI Web of Knowledge, EMBASE, and Cochrane Library databases up until February 1, 2016 for eligible studies which were matched to search subjects. Either fixed-effects or random-effects models were used to estimate the summary risk incorporated between study variations.Results 19 studies comprising a total of 39,136 participants and 7924 cases were included in the meta-analysis. Our findings showed that an obvious association of elevated CRP levels with T2DM risk (relative risk [RR] 1.48 [95% CI 1.26-1.71]), with the absence of publication bias. For IL-6, the meta-analysis involved 16 cohorts with a total of 24,929 participants and 4751 cases. Using data from all trials, a strong positive correlation (1.32 [1.14, 1.51]) was observed between basal plasma IL-6 and T2DM, whereas relatively lower relation between TNF-α (1.16 [0.87, 1.45]), IL-18 (1.45 [1.16, 1.73]), IL-1β (0.87, [0.59, 1.15]) and independently increased risk to occurrence of T2DM. Conversely, we also found that the level of adiponectin decreased significantly in patients with T2DM. Sensitivity analyses further supported the associations.Conclusions This meta-analysis indicates that T2DM risk as whole was strongly associated with elevated levels of inflammatory cytokines (IL-1β, IL-6, IL-18, CRP), TNF-α and low levels of adiponectin. Despite an overall detectable association in the meta-analysis, considerable heterogeneity existed between studies. Further work is needed, it seems clear that a complex interplay of inflammation and the development of DM. Moreover, these biomarkers are predictors of T2DM subjects and should take more attention to measure levels of these as well as to target therapy/interventions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lower adiponectin concentration is associated with the development of insulin resistance and type 2 diabetes mellitus.
“Its lower concentration is associated with the development of IR and T2DM [39].”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [39]
As adipose tissue volume increases, the concentration of adiponectin declines.
“As adipose tissue volume increases, the concentration of adiponectin, having an insulin-sensitizing and anti-inflammatory impact, declines.”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [39]
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · see citing works
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · see citing works
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915 · see citing works
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works
Armijo‐Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01516.x · Cited by 1,539 · see citing works
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493 · see citing works
Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., et al. (2000) · Blood · doi:10.1182/blood.v96.5.1723 · Cited by 1,294 · see citing works
Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1057 · Cited by 1,275 · see citing works
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257 · cited 1× · see citing works
“Our results suggest that levels of adiponectin correlated inversely with incident diabetes, which are similar with previous literatures [45,46].”
ResultGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114 · see citing works
Adiponectin and development of type 2 diabetes in the Pima Indian population
Lindsay, R. S., Funahashi, T., Hanson, R. L., Matsuzawa, Y., Tanaka, S., Tataranni, P. A., Knowler, W. C., & Krakoff, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09335-2 · Cited by 1,094 · see citing works
Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Duncan, B. B., Schmidt, M. I., Pankow, J. S., Ballantyne, C. M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A. R., & Heiss, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1799 · Cited by 1,036 · see citing works
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,006 · see citing works
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991 · see citing works
Inflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820 · see citing works
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Hu, F. B., Meigs, J. B., Li, T. Y., Rifai, N., & Manson, J. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.693 · Cited by 788 · see citing works
The role of TNFα and TNF receptors in obesity and insulin resistance
Hotamisligil, G. S. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00490.x · Cited by 780 · see citing works
Freeman, D. J., Norrie, J. D., CASLAKE, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N. A., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 720 · see citing works
Targeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690 · see citing works
The Role of Inflammatory Cytokines in Diabetes and Its Complications
King, G. L. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080246 · Cited by 680 · see citing works
The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly
Barzilay, J. I., Abraham, L., Heckbert, S. R., Cushman, M., Kuller, L. H., Resnick, H. E., & Tracy, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2384 · Cited by 543 · see citing works
Han, T. S., Sattar, N. A., Williams, K., González‐Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 514 · see citing works
Inflammation and type 2 diabetes
Calle, M. C., & Fernández, M. L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.006 · Cited by 492 · see citing works
C-Reactive Protein as a Predictor for Incident Diabetes Mellitus Among Middle-aged Men
Thorand, B., Löwel, H., Schneider, A. L. C., Kolb, H., Meisinger, C., Fröhlich, M., & Köenig, W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.93 · Cited by 370 · see citing works
Mirza, S., Hossain, M., Mathews, C., Martinez, P., Pino, P., Gay, J. L., Rentfro, A., McCormick, J. B., & Fisher-Hoch, S. P. (2012) · Cytokine · doi:10.1016/j.cyto.2011.09.029 · Cited by 358 · see citing works
The role of interleukins in insulin resistance and type 2 diabetes mellitus
Fève, B., & Bastard, J.-P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.62 · Cited by 343 · see citing works
Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
Krakoff, J. A., Funahashi, T., Stehouwer, C. D. A., Schalkwijk, C. G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P. A., Hanson, R. L., Knowler, W. C., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1745 · Cited by 334 · see citing works
Role of IL-1β in type 2 diabetes
Dinarello, C. A., Donath, M. Y., & Mandrup-Poulsen, T. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833bf6dc · Cited by 330 · see citing works
Guha, M., Bai, W., Nadler, J. L., & Natarajan, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.23.17728 · Cited by 308 · see citing works
Ruan, H., Miles, P. D. G., Ladd, C. M., Ross, K. N., Golub, T. R., Olefsky, J. M., & Lodish, H. F. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3176 · Cited by 297 · see citing works
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Laaksonen, D. E., NISKANEN, L. K., Nyyss�nen, K., Punnonen, K. R. A., Tuomainen, T., Valkonen, V.-P., Salonen, R. M., & Salonen, J. T. (2004) · Diabetologia · doi:10.1007/s00125-004-1472-x · Cited by 291 · see citing works
MOROHOSHI, M., Fujisawa, K., Uchimuraa, I., & Numano, F. (1996) · Diabetes · doi:10.2337/diab.45.7.954 · Cited by 281 · see citing works
Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes
Dehghan, A., Kardys, I., de Maat, M. P. M., Uitterlinden, A. G., Sijbrands, E. J. G., Bootsma, A. H., Stijnen, T., Albert Hofman, D., Schram, M. T., & Witteman, J. C. M. (2007) · Diabetes · doi:10.2337/db06-0922 · Cited by 258 · see citing works
Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes
Thorand, B., Kolb, H., Baumert, J. J., Köenig, W., Chambless, L. E., Meisinger, C., Illig, T., Martin, S., & Herder, C. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2932 · Cited by 216 · see citing works
Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis
Lee, C.-T., Adler, A., Sandhu, M. S., Sharp, S. J., Forouhi, N. G., Erqou, S. A., Luben, R., Bingham, S. A., Khaw, K., & Wareham, N. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1338-3 · Cited by 201 · see citing works
Inflammation and the Incidence of Type 2 Diabetes
Bertoni, A. G., Burke, G. L., Owusu, J. A., Carnethon, M. R., Vaidya, D. M., Barr, R. G., Jenny, N. S., Ouyang, P., & Rotter, J. I. (2010) · Diabetes Care · doi:10.2337/dc09-1679 · Cited by 201 · see citing works
Liu, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1676 · Cited by 198 · see citing works
Adipokines and Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Lowe, G. D. O., Rumley, A., Cherry, L., Whincup, P. H., & Sattar, N. A. (2007) · Diabetes Care · doi:10.2337/dc06-2416 · Cited by 194 · see citing works
Influence of TNF-α and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Krogh‐Madsen, R., Plomgaard, P., Møller, K., Mittendorfer, B., & Pedersen, B. K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2005 · Cited by 181 · see citing works
Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers
Thorand, B., Baumert, J. J., Kolb, H., Meisinger, C., Chambless, L. E., Köenig, W., & Herder, C. (2007) · Diabetes Care · doi:10.2337/dc06-1693 · Cited by 173 · see citing works
Diabetes and inflammation: Fundamental aspects and clinical implications
Garcia, C., Fève, B., Ferré, P., Halimi, S., Baïzri, H., Bordier, L., Guiu, G., Dupuy, O., Bauduceau, B., & Mayaudon, H. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.001 · Cited by 160 · see citing works
Doi, Y., Kiyohara, Y., Kubo, M., Ninomiya, T., Wakugawa, Y., Yonemoto, K., Iwase, M., & Iida, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2497 · Cited by 145 · see citing works
Perego, L., Pizzocri, P., Corradi, D., Maisano, F., Paganelli, M., Fiorina, P., Barbieri, M., Morabito, A., Paolisso, G., Folli, F. B., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1963 · Cited by 123 · see citing works
Marques-Vidal, P. M., Schmid, R., Bochud, M., Bastardot, F., von Känel, R., Paccaud, F. M., Glaus, J., Preisig, M., Waeber, G., & Vollenweider, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051768 · Cited by 95 · see citing works
Thorand, B., Zierer, A., Baumert, J. J., Meisinger, C., Herder, C., & Köenig, W. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03043.x · Cited by 91 · see citing works
Adipokines and Incident Type 2 Diabetes in an Aboriginal Canadian Population
Ley, S. H., Harris, S. B., Connelly, P. W., Mamakeesick, M., Gittelsohn, J., Hegele, R. A., Retnakaran, R. R., Zinman, B., & Hanley, A. J. (2008) · Diabetes Care · doi:10.2337/dc08-0036 · Cited by 78 · see citing works
Circulating IL-18 and the risk of type 2 diabetes in women
Hivert, M., Sun, Q., Shrader, P. J., Mantzoros, C. S., Meigs, J. B., & Hu, F. B. (2009) · Diabetologia · doi:10.1007/s00125-009-1455-z · Cited by 66 · see citing works
Zhang, M., Chen, P., Chen, S., Sun, Q., Qc, Z., Jy, C., Yx, L., Xh, C., Ren, M., & Wang, J.-K. (2014) · PubMed · Cited by 65 · see citing works
Good clinical practice guidelines for care home residents with diabetes: an executive summary
Sinclair, A. J., & on behalf of the Task and Finish Group of Diabetes UK (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03320.x · Cited by 44 · see citing works
Sarangi, R., Padhi, S., Mohapatra, S., Swain, S., Padhy, R. K., Mandal, M. K., Patro, S. K., & Kumar, S. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.05.015 · Cited by 26 · see citing works
Racial Differences in Association of Elevated Interleukin-18 Levels With Type 2 Diabetes
Negi, S., Pankow, J. S., Fernstrom, K. M., Hoogeveen, R. C., Zhu, N., Couper, D. J., Schmidt, M. I., Duncan, B. B., & Ballantyne, C. M. (2012) · Diabetes Care · doi:10.2337/dc11-1957 · Cited by 19 · see citing works
Hosseinzadeh‐Attar, M. J., Mohammadi, S., Karimi, M., Hossein‐Nezhad, A., Hosseini, S. H., Eshraghian, M. R., Jafari, N. V., Rahmani, M., Karimi, F., & Nezhad, M. K. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.02.027 · Cited by 8 · see citing works
Cosentino, M., & Picozzi, M. (2011) · Bioethics · doi:10.1111/j.1467-8519.2011.01936.x · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors
Fiuza-Luces, C., Santos-Lozano, A., Joyner, M., Carrera-Bastos, P., Picazo, O., Zugaza, J. L., Izquierdo, M., Ruilope, L. M., & Lucia, A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0065-1 · Cited by 803 · see citing works
Cytokines and abnormal glucose and lipid metabolism
Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282 · see citing works
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274 · see citing works
Flavonoids as Antiobesity Agents: A Review
Rufino, A. T., Costa, V. M., Carvalho, F., & Fernandes, E. (2021) · Medicinal Research Reviews · doi:10.1002/med.21740 · Cited by 174 · see citing works
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148 · see citing works
Huth, C., von Toerne, C., Schederecker, F., de las Heras Gala, T., Herder, C., Kronenberg, F., Meisinger, C., Rathmann, W., Koenig, W., Waldenberger, M., et al. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-018-0475-8 · Cited by 56 · see citing works
Li, T., Ni, L., Zhao, Z., Liu, X., Lai, Z., Di, X., Xie, Z., Song, X., Wang, X., Zhang, R., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12475 · Cited by 36 · see citing works
Self-citationMa, B., Wang, X., Ren, H., Li, Y., Zhang, H., Yang, M., & Li, J. (2023) · BMC Cancer · doi:10.1186/s12885-023-11077-w · Cited by 36 · see citing works
The Relationship of adiponectin level and<i>ADIPOQ</i>gene variants with BMI among young adult women
Khabour, O. F., Alomari, M. A., & Abu Obaid, A. A. (2018) · Dermato-Endocrinology · doi:10.1080/19381980.2018.1477902 · Cited by 21 · see citing works
- Authors
- Liu, C., Feng, X., Li, Q., Wang, Y., Li, Q., & Hua, M.
- Affiliations
- Nanjing First Hospital (CN)
- Corresponding author
- Li, Qi
- Li, Qian
- Hua, Majian
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 86
- Pages
- 100-109
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W2500162161
- Cited by
- 470
- References
- 53
- Citations by year
- 2026: 27 · 2025: 41 · 2024: 67 · 2023: 47 · 2022: 55 · 2021: 74 · 2020: 59 · 2019: 42 · 2018: 36 · 2017: 19 · 2016: 2 · 2015: 1
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cytokine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nanjing Medical University
- National Natural Science Foundation of China (81200594)
- Jiangsu Planned Projects of Postdoctoral Research Funds
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, adiponectin, TNF-α, inflammatory cytokines, interleukin-6, IL-1β, IL-18, C-reactive protein, insulin resistance, inflammation, adipokines, prospective cohort, incident diabetes risk, risk prediction model
- MeSH terms
- Adult, Animals, C-Reactive Protein, Diabetes Mellitus, Type 2, Disease Models, Animal, Female, Humans, Male, Middle Aged, Risk Factors, Tumor Necrosis Factor-alpha, Models, Statistical, Interleukin-6, Cytokines, Inflammation Mediators, Interleukin-18, Mice, Adiponectin, Interleukin-1beta, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
